269 / 1224
/
SBRT not fundamentally different, “just” more convenient
•
Retrospective study
•
160 patients
•
SBRT: 54Gy in 3F
•
AHRT: 70.2Gy in 26Fx
No difference in any in
OS, RF, DF, LC
No difference in toxicity
Comparison of accelerated hypofractionation and stereotactic body
radiotherapy for Stage 1 and node negative Stage 2 non-small cell
lung cancer (NSCLC)
Lucas Lung Cancer 2014
13.06.2016
Matthias Guckenberger - ESTRO SBRT Course 2016 Athens
27